CEWG Executive Committee
Anna D. Barker, PhD, FAACR
(2023-2025)Chief Strategy Officer
Lawrence J. Ellison Institute for Transformative Medicine
University of Southern California
Los Angeles, California
Jeffrey P. Townsend, PhD
(2023-2025)Elihu Professor of Biostatistics
Professor of Ecology and Evolutionary Biology
Yale School of Public Health
New Haven, Connecticut
Frank H. Laukien, PhD
(2023-2024)Chairman, President and CEO
Bruker Corporation
Billerica, Massachusetts
Member, The Oncology Think Tank;
Visiting Scholar, Department of Chemistry and Chemical Biology
Harvard University
Cambridge, Massachusetts
Charles Swanton, MBPhD, FAACR
(2023-2024)Royal Society Napier Professor
The Francis Crick Institute and UCL Cancer Institute
Cancer Evolution and Genome Instability Laboratory
The Francis Crick Institute and UCL Cancer Institute
London, United Kingdom
Franziska Michor, PhD
(2021-2024)Professor of Computational Biology
Departments of Data Sciences, Biostatistics, and Stem Cell and Regenerative Biology
Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health, Harvard University
Boston, Massachusetts
Kenneth J. Pienta, MD
(2021-2024)The Donald S. Coffey Professor of Urology
Professor of Oncology, Pharmacology, and Molecular Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland
George H. Poste, DVM, PhD, FRCPath, FmedSci, CBE, FRS
(2021-2024)Director and Chief Scientist, Complex Adaptive Systems Initiative
Regents’ Professor and Del E. Webb Professor of Health Innovation
Arizona State University
Tempe, Arizona
Susan M. Rosenberg, PhD
(2021-2024)Ben F. Love Chair in Cancer Research
Leader, Mechanisms in Cancer Evolution Program
Professor of Molecular and Human Genetics, Biochemistry and Molecular Biology, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, Translational Biology, and Molecular Medicine
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas
Jason A. Somarelli, PhD
(2021-2024)Assistant Professor of Medicine
Director of Research
Duke Comparative Oncology Group
Duke Cancer Institute
Durham, North Carolina